CDX model based genome-scale CRISPR KO screens for modulators of KRAS (G12C) inhibitor sensitivity

被引：0
|
作者：
Zhao, Haixin
Zhai, Fangzheng
Li, Bin
Fan, Qiangqiang
Peng, Zhengang
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-257
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
257
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Characterization of a panel of CRISPR/Cas9 engineered KRAS G12C inhibitorresistant tumor models
    Zhou, Jun
    Hua, Li
    Feng, Jian
    Bao, Ning
    Zhang, Dan
    Wang, Jingjing
    Putker, Marrit
    Bourre, Ludovic
    CANCER RESEARCH, 2024, 84 (06)
  • [22] Selinexor (XPO1 inhibitor) in combination with tepotinib (MET inhibitor) potentially inhibits SHOC2 and KRAS G12C in KRAS G12C mutant non-small cell lung cancer
    Rosell, R.
    Jain, A.
    Codony-Servat, J.
    Shivamallu, C.
    Kollur, S. P.
    Prasad, A.
    Vishwanath, P.
    Jantus Lewintre, E.
    Ito, M.
    Cardona Zorrilla, A. F.
    Arrieta Rodriguez, O. G.
    Pedraz-Valdunciel, C.
    Gonzalez Nieto, J.
    Aguilar, A.
    Molina-Vila, M. A.
    Gonzalez Cao, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1188 - S1188
  • [23] Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy
    Zhang, Junmin
    Zhang, Juanhong
    Leung, Elaine Lai-Han
    Yao, Xiao-Jun
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (02) : 101 - 106
  • [24] The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
    Canon, Jude
    Rex, Karen
    Saiki, Anne Y.
    Mohr, Christopher
    Cooke, Keegan
    Bagal, Dhanashri
    Gaida, Kevin
    Holt, Tyler
    Knutson, Charles G.
    Koppada, Neelima
    Lanman, Brian A.
    Werner, Jonathan
    Rapaport, Aaron S.
    San Miguel, Tisha
    Ortiz, Roberto
    Osgood, Tao
    Sun, Ji-Rong
    Zhu, Xiaochun
    McCarter, John D.
    Volak, Laurie P.
    Houk, Brett E.
    Fakih, Marwan G.
    O'Neil, Bert H.
    Price, Timothy J.
    Falchook, Gerald S.
    Desai, Jayesh
    Kuo, James
    Govindan, Ramaswamy
    Hong, David S.
    Ouyang, Wenjun
    Henary, Haby
    Arvedson, Tara
    Cee, Victor J.
    Lipford, J. Russell
    NATURE, 2019, 575 (7781) : 217 - +
  • [25] Overcoming KRAS G12C inhibitor resistance with a chaperone-mediated protein degrader (CHAMP)
    Endrino, Ines Pulido
    Luan, Qiyue
    Graeber, Jennifer
    Borger, Brianna
    Ying, Chenghao
    Li, Jinhua
    Yang, Zimo
    Wang, Zhiyong
    Wang, Yaya
    Sun, Yuetong
    Dai, Yan
    Papautsky, Ian
    Prince, Thomas L.
    Wang, Guoqiang
    Foley, Kevin P.
    Ying, Weiwen
    Shimamura, Takeshi
    CANCER RESEARCH, 2023, 83 (08)
  • [26] Overcoming KRAS G12C inhibitor resistance with chaperone-mediated protein degrader in NSCLC
    Pulido, Ines
    Graeber, Jennifer M.
    Borger, Brianna C.
    Foley, Kevin P.
    Ying, Weiwen
    Ying, Chenghao
    Li, Jinhua
    Wang, Yaya
    Sun, Yuetong
    Dai, Yan
    Wang, Guoqiang
    Prince, Thomas L.
    Shimamura, Takeshi
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [27] The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
    Jude Canon
    Karen Rex
    Anne Y. Saiki
    Christopher Mohr
    Keegan Cooke
    Dhanashri Bagal
    Kevin Gaida
    Tyler Holt
    Charles G. Knutson
    Neelima Koppada
    Brian A. Lanman
    Jonathan Werner
    Aaron S. Rapaport
    Tisha San Miguel
    Roberto Ortiz
    Tao Osgood
    Ji-Rong Sun
    Xiaochun Zhu
    John D. McCarter
    Laurie P. Volak
    Brett E. Houk
    Marwan G. Fakih
    Bert H. O’Neil
    Timothy J. Price
    Gerald S. Falchook
    Jayesh Desai
    James Kuo
    Ramaswamy Govindan
    David S. Hong
    Wenjun Ouyang
    Haby Henary
    Tara Arvedson
    Victor J. Cee
    J. Russell Lipford
    Nature, 2019, 575 : 217 - 223
  • [28] Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity
    Li, Ling
    Wu, Yinrong
    Yang, Zichao
    Xu, Chenglong
    Zhao, Huiting
    Liu, Jin
    Chen, Jingxuan
    Chen, Jianjun
    BIOORGANIC CHEMISTRY, 2021, 117
  • [29] Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
    Xu, Jie
    Lim, Ngiap-Kie
    Timmerman, Jacob C.
    Shen, Jeff
    Clagg, Kyle
    Orcel, Ugo
    Bigler, Raphael
    Trachsel, Etienne
    Meier, Roland
    White, Nicholas A.
    Burkhard, Johannes A.
    Sirois, Lauren E.
    Tian, Qingping
    Angelaud, Remy
    Bachmann, Stephan
    Zhang, Haiming
    Gosselin, Francis
    ORGANIC LETTERS, 2023, 25 (19) : 3417 - 3422
  • [30] Research progress on small molecule inhibitors targeting KRAS G12C with acrylamide structure and the strategies for solving KRAS inhibitor resistance
    Jiang, Zhiyan
    Li, Yan
    Zhou, Xin
    Wen, Jie
    Zheng, Pengwu
    Zhu, Wufu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 100
12345